Commonwealth Bank of Australia’s Core Laboratories CLB Stock Holding History

Commonwealth Bank of Australia’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,300	Closed	-$277K	–	204
2019 Q2	$277K	Buy	5,300 +2,200	+71%	+$129K	﹤0.01%	863
2019 Q1	$213K	Hold	3,100	–	–	﹤0.01%	861
2018 Q4	$184K	Buy	3,100 +600	+24%	+$51.8K	﹤0.01%	862
2018 Q3	$289K	Buy	+2,500	New	+$282K	﹤0.01%	837
2017 Q4	–	Sell	-100	Closed	-$9K	–	853
2017 Q3	$9K	Sell	100 -800	-89%	-$77.5K	﹤0.01%	768
2017 Q2	$91K	Buy	900 +200	+29%	+$21.6K	﹤0.01%	719
2017 Q1	$81K	Sell	700 -68,770	-99%	-$7.99M	﹤0.01%	734
2016 Q4	$8.34M	Sell	69,470 -2,301	-3%	-$255K	0.1%	138
2016 Q3	$8.06M	Sell	71,771 -5,838	-8%	-$672K	0.1%	131
2016 Q2	$9.62M	Sell	77,609 -7,967	-9%	-$962K	0.11%	122
2016 Q1	$9.62M	Sell	85,576 -1,728	-2%	-$180K	0.12%	119
2015 Q4	$9.49M	Buy	87,304 +69	+0.1%	+$7.9K	0.12%	118
2015 Q3	$8.71M	Sell	87,235 -1,842	-2%	-$200K	0.11%	122
2015 Q2	$10.2M	Buy	89,077 +88,577	+17,715%	+$10.7M	0.14%	104
2015 Q1	$52K	Buy	500 +100	+25%	+$10.7K	﹤0.01%	699
2014 Q4	$48K	Hold	400	–	–	﹤0.01%	692
2014 Q3	$59K	Hold	400	–	–	﹤0.01%	733
2014 Q2	$67K	Sell	400 -2,800	-88%	-$498K	﹤0.01%	715
2014 Q1	$635K	Hold	3,200	–	–	﹤0.01%	966
2013 Q4	$611K	Buy	3,200 +400	+14%	+$74.4K	﹤0.01%	941
2013 Q3	$474K	Hold	2,800	–	–	﹤0.01%	987
2013 Q2	$425K	Buy	+2,800	New	+$397K	﹤0.01%	985

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Commonwealth Bank of Australia's CLB Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 5,300 shares — an estimated $277K sold.

Commonwealth Bank of Australia first reported a position in CLB in Q2 2013 and held it in 22 quarters. The position peaked at $10.2M in Q2 2015. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Commonwealth Bank of Australia reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 5,300 Core Laboratories shares in Q3 2019, an estimated $277K.
Commonwealth Bank of Australia first reported a position in Core Laboratories in Q2 2013 and held it in 22 quarters.
Commonwealth Bank of Australia's Core Laboratories position peaked at $10.2M in Q2 2015.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.